According to Semler Scientific 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.0075. At the end of 2022 the company had a P/E ratio of 15.5.
Year | P/E ratio | Change |
---|---|---|
2022 | 15.5 | -56.72% |
2021 | 35.8 | -18.88% |
2020 | 44.1 | 114.22% |
2019 | 20.6 | -50.89% |
2018 | 42.0 | -252.07% |
2017 | -27.6 | 851.25% |
2016 | -2.90 | 94.84% |
2015 | -1.49 | -13.43% |
2014 | -1.72 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Hologic HOLX | 38.9 | 288.99% | ๐บ๐ธ USA |
Waters Corporation WAT | 27.7 | 176.86% | ๐บ๐ธ USA |
Fonar Corporation
FONR | 10.9 | 9.05% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.